Experimental Factor Ontology
6782 terms(s) returned
| Term Type: | Record: 6151 to 6200 of 6782 Records | Page: 124 of 136, First Previous Next Last | Show Records Per Page |
- astacin-like metalloendopeptidase
- astacin-like metalloendopeptidase (human)
- astacin-like metalloendopeptidase measurement
- astaxanthin
- astaxanthin measurement
- asthenia
- asthma
- asthma exacerbation measurement
- asthma symptoms measurement
- asthma, aspirin-induced, susceptibility to
- asthma, nasal polyps, and aspirin intolerance
- astroblastoma
- astroblastoma, MN1-altered
- astrocyte
- astrocytic phosphoprotein PEA-15
- astrocytic phosphoprotein PEA-15 (human)
- astrocytic tumor
- astrocytoma (excluding glioblastoma)
- astrocytoma, IDH-mutant, grade 3
- asymmetric dimethylarginine measurement
- asymmetrical dimethylarginine measurement
- asymptomatic neurocognitive impairment
- atactic disorder
- ataxia - deafness - intellectual disability syndrome
- ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome
- ataxia - telangiectasia variant
- ataxia neuropathy spectrum
- ataxia telangiectasia
- ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia
- ataxia, intention tremor, and hypotonia syndrome, childhood-onset
- ataxia, spastic, childhood-onset, autosomal recessive, with optic atrophy and intellectual disability
- ataxia-hypogonadism-choroidal dystrophy syndrome
- ataxia-pancytopenia syndrome
- ataxia-tapetoretinal degeneration syndrome
- ataxia-telangiectasia-like disorder
- ataxic cerebral palsy
- ataxin-10
- ataxin-10 (human)
- ataxin-2
- ataxin-2-like protein
- ataxin-3
- ataxin-3 (human)
- atazanavir
- atazanavir measurement
- atelosteogenesis
- atelosteogenesis type I
- atelosteogenesis type II
- atelosteogenesis type III
- atenolol
- atenolol measurement